In the morning of April 4, 2018, Dr. Ming-Wei Wang (Dean, School of Pharmacy, Fudan University and Director, The National Center for Drug Screening/The Chinese National Compound Library) visited Novo Nordisk’s research and development headquarters located at Copenhagen (Denmark). He was warmly received by Drs. Peter Kurtzhals (Senior Vice President, Global Development) and Søren Tullin (Corporate Vice President, Discovery Biology & Technology). They mainly discussed opportunities and prospects of further expanding bilateral and multilateral co-operations in the new era. The two sides reached an agreement relative to the near-term execution plan.